Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond.

about

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond.

Item

http://www.wikidata.org/entity/Q38956309

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Development of personalized tr ...... the EGFR mutations and beyond.

@en

type

Item

label

Development of personalized tr ...... the EGFR mutations and beyond.

@en

prefLabel

Development of personalized tr ...... the EGFR mutations and beyond.

@en

P1476

Development of personalized tr ...... the EGFR mutations and beyond

@en

P2093

Kenichi Suda

http://www.w3.org/2001/XMLSchema#string

Tetsuya Mitsudomi

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

P304

43-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/LCTT.S49603

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tetsuya Mitsudomi

Kenichi Suda

P577

2013-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28210134

http://www.w3.org/2001/XMLSchema#string

P932

5217442

http://www.w3.org/2001/XMLSchema#string